Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002987377 | SCV003707950 | uncertain significance | Inborn genetic diseases | 2021-05-20 | criteria provided, single submitter | clinical testing | The c.470A>G (p.Y157C) alteration is located in exon 7 (coding exon 6) of the SACS gene. This alteration results from a A to G substitution at nucleotide position 470, causing the tyrosine (Y) at amino acid position 157 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003140206 | SCV003820612 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-11-11 | criteria provided, single submitter | clinical testing |